Order Article Reprints

Ko M, Chang SY, Byun SY, Ianevski A, Choi I, Pham Hung d’Alexandry d’Orengiani A-L, Ravlo E, Wang W, Bjørås M, Kainov DE, et al. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses. 2021; 13(4):651. https://doi.org/10.3390/v13040651

Ko, Meehyun, So Young Chang, Soo Young Byun, Aleksandr Ianevski, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, Erlend Ravlo, Wei Wang, Magnar Bjørås, Denis E. Kainov, and et al. 2021. "Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19" Viruses 13, no. 4: 651. https://doi.org/10.3390/v13040651

Ko, M., Chang, S. Y., Byun, S. Y., Ianevski, A., Choi, I., Pham Hung d’Alexandry d’Orengiani, A.-L., Ravlo, E., Wang, W., Bjørås, M., Kainov, D. E., Shum, D., Min, J.-Y., & Windisch, M. P. (2021). Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses, 13(4), 651. https://doi.org/10.3390/v13040651